The U.S. Food and Drug Administration (FDA) relaxed its regulatory stance on unauthorized vaping products and nicotine pouches. This policy shift benefits large tobacco companies by allowing certain products to remain on the market during the review process.
The agency will now apply enforcement discretion to products with pending premarket tobacco product applications (PMTAs) that meet specific standards. This change significantly impacts Altria Group, the manufacturer of NJOY e-vapor products and on! nicotine pouches.
The previous pre-market authorization process acted as a major hurdle for the industry. This updated approach may accelerate the path to market for new products and strengthen Altria's competitive standing in the smoke-free category.